• Nitrocefin for Metallo-β-Lactamase Characterization in Em...

  2025-09-23

  Explore how Nitrocefin, a chromogenic cephalosporin substrate, enables advanced colorimetric β-lactamase assays for studying β-lactamase enzymatic activity and antibiotic resistance mechanisms in multidrug-resistant bacteria, including Elizabethkingia anophelis.

• Nitrocefin for Advanced β-Lactamase Detection in Emerging...

  2025-09-22

  Explore the nuanced application of Nitrocefin as a chromogenic cephalosporin substrate for β-lactamase detection in multidrug-resistant pathogens. This article offers new perspectives on quantitative β-lactamase activity measurement and antibiotic resistance profiling in the context of metallo-β-lactamase dissemination.

• Nitrocefin in Mechanistic Studies of Metallo-β-Lactamase-...

  2025-09-19

  Explore the advanced applications of Nitrocefin as a chromogenic cephalosporin substrate for dissecting β-lactamase enzymatic activity, with a focus on novel metallo-β-lactamases in emerging pathogens. This article provides a rigorous examination of Nitrocefin’s role in elucidating microbial antibiotic resistance mechanisms and β-lactamase inhibitor screening.

• Nitrocefin Applications in β-Lactamase Detection and Anti...

  2025-09-18

  Explore how Nitrocefin, a chromogenic cephalosporin substrate, enables precise β-lactamase detection and advances research into antibiotic resistance profiling. This article offers a rigorous overview of Nitrocefin’s use in enzymatic activity measurement and inhibitor screening within multidrug-resistant bacterial contexts.

• Overexpression of AR in a

  2025-03-03

  

  Overexpression of AR in a transgenic mouse model leads to a capsular cataract phenotype involving proliferation and formation of a fibrotic plaque of cells reminiscent of cells at the posterior (±)-J 113397 receptor in PCO [17]. To investigate the molecular mechanism that could link AR expression to

• The fact that Yoda can activate

  2025-03-03

  

  The fact that Yoda1 can activate Piezo1 in the absence of other cellular components other than a cell membrane [2], suggests that it may directly interact with and activate Piezo1. However, this does not preclude Yoda1 from interacting and activating non-Piezo channels, particularly in endothelial c

• br Methodology In this paper

  2025-03-03

  

  Methodology In this paper, mechanical properties of G-actin are examined. To do so, three different external tensile loads are exerted to the protein. As illustrated in Fig. 1, Arp2/3 complex binds to the one sides of mother Eeyarestatin I mg and leads to the growth of a new daughter filament at

• br Autophagy and cell death pathways in ischemic

  2025-03-03

  

  Autophagy and cell death pathways in ischemic stroke Although very important for the effects on post-ischemic Lauric Acid australia injury, autophagy is not the only mechanism of action involved in cell death. Necrosis and apoptosis are two other distinct forms of cell death with great differenc

• br Conclusion br Acknowledgments and

  2025-03-01

  

  Conclusion Acknowledgments and disclosure We thank Ms. Crystal Wylie for her help in the preparation of the manuscript. The development of the database upon which analyses of this study were dependent was supported by PO1 DC 00161 from the National Institute on Deafness and Other Communication

• Further validation for a role in LOX pathway in

  2025-03-01

  

  Further validation for a role in 12/15-LOX pathway in mediating adipocyte function comes from studies revealing a regulatory role of lipocalin-2 on 12/15-LOX activity. Lipocalin-2, a glycoprotein member of the lipocalin superfamily, is a novel abundant adipokine implicated in obesity-mediated inflam

• Some of the mechanisms that involve LOX as

  2025-03-01

  

  Some of the mechanisms that involve 12-LOX as a potential pathogenic enzyme are illustrated in Fig. 2. Direct β cell effects associated with the stimulation of 12-LOX activity include the activation of second messengers c-Jun N-terminal kinase and p38 MAPK, both of which show increased phosphorylati

• br Concluding Remarks and Future Perspectives While

  2025-03-01

  

  Concluding Remarks and Future Perspectives While postmortem human CHIR-99021 material is relatively sparse and has inherent limitations as discussed above, additional investigations could benefit from analysis of in vitro cellular models to corroborate findings in patient material. Generation of

• Another interesting interaction concerns NMDA preconditionin

  2025-03-01

  

  Another interesting interaction concerns NMDA preconditioning to protect against glutamate neurotoxicity. It has been shown that an A1R antagonist prevented neuroprotection evoked by NMDA preconditioning against glutamate-induced cellular damage in cerebellar granule cells. In this study, the functi

• br New AMPK activators Fenofibrate is a

  2025-03-01

  

  New AMPK activators Fenofibrate is a drug of the fibrate class used for the treatment of dyslipidemia [53] but is also an agent that could alleviate DN-induced alterations through AMPK activation (Fig. 2). Streptozotocin-induced diabetic rats treated with fenofibrate improved in not only renal fu

• The results show that a tonic action

  2025-03-01

  

  The results show that a tonic action of ACh on respiration is lacking. However, it is clear that muscarinic cholinergic mechanisms can modulate both eupneic breathing and the cough reflex. When these mechanisms are brought into action is obscure and only tentative proposals can be advanced. ACh in t

15993 records 1/1067 page Next 12345 下5页 Last page